CAR-T technology has revolutionized the approach to personalized medicine in cancer care. But limitations like high cost, toxicities, and treatment accessibility have historically made these treatments difficult to scale. With the help of innovative technologies and digital tools, point-of-care manufacturing, and AI-driven approaches, the next-generation of CAR-T therapies is looking bright for patients and developers alike.
